ACESO LIFE SCI (00474): Completion of loan agreement refinancing arrangement.
Sinomab Life Sciences Technology (00474) announced the refinancing arrangement related to the 2018 financing agreement. By 2025...
ACESO LIFE SCI (00474) announced the refinancing arrangement for the 2018 financing agreement. All conditions precedent under the 2025 loan agreement have been met, and completion of delivery was on September 26, 2025. With the completion of this delivery, the company has been provided with a total financing amount of approximately 87.3 million, of which approximately 70.3 million has been drawn down today to fully repay the UK loans and related transaction costs. The remaining 17 million will be used for capital expenditures for the company's UK properties over the next one to two years. The company will begin planning for a large-scale renovation project on its UK properties, including upgrading its main facilities and ancillary facilities, in order to increase rental income and capital value of the UK properties.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






